In this study, Hedgehog signaling in dermal papilla fibroblasts was found to accelerate hair growth and induce folliclemultiplication in mice via the SCUBE3/TGF-β pathway, with some effects observed in human scalp hair follicles.
41 citations
,
September 2010 in “Journal of dermatological science”
This study suggests that mesenchymal stem cell-induced dermal papilla-like tissues can generate new hair follicles in mice, indicating potential for developing hair cell therapy using stem cells.
19 citations
,
April 2010 in “Journal of Dermatological Treatment”
This study found that partial follicular units extracted from the donor area can survive and regenerate new hairs at their original site and when transplanted, effectively creating two hair follicles from one.
4 citations
,
November 2006 in “Dermatologic Surgery”
This study found that the survival of transplanted transected hair follicles is related to the level of transection, but their growth at the recipient site is not satisfactory, leading to a recommendation against transplanting sectioned parts.
This study concluded that while transected hair follicles can survive after transplantation in follicular unit extraction, their growth rate is unsatisfactory, and they are thinner than original follicles.
A breakthrough in hair follicle cultivation using induced pluripotent stem cells (iPSCs) has been achieved, producing large hair follicles suitable for transplantation. Clinical trials for this hair multiplication technology are planned in partnership with Yinguan Biotechnology.
Hair cell therapy and follicle cloning are still in experimental stages, with treatments like hair multiplication and regenerative hair therapy being marketed but not yet proven to create unlimited new follicles. There is skepticism about the effectiveness and legitimacy of these treatments, with some considering them scams.
Hair/scalp cloning for unlimited transplants is likely a decade away, with prior transplants not significantly affecting future options. Advances in AI and research in wound-induced hair neogenesis are promising, but infrastructure and technology constraints remain challenges.
Chinese researchers have successfully created hair follicles in vitro, potentially offering unlimited hair for transplantation and a cure for hair loss. They plan to test these follicles in vivo on human scalps.
HairClone is offering a Dermal Papilla Cell Hair Multiplication procedure in Guatemala, raising questions about its effectiveness and regulatory reasons for the location. Users express skepticism and curiosity about the treatment's success and potential costs.